-
Hbs Club of Connecticut
Distance: 0.4 Mi47 Sachem Ln
06830 Greenwich -
PBF Energy
Distance: 0.1 Mi1 Sound Shore Dr Ste 303
06830-7251 Greenwich -
Synergex Group
Distance: 0.2 Mi19 Cobb Island Dr
06830-7244 Greenwich -
Atlas Holdings LLC
Distance: 0.1 Mi1 Sound Shore Dr Ste 302
06830-7251 Greenwich -
Life Science Group Inc
Distance: 0.1 Mi1 Sound Shore Dr Ste 205
06830-7251 Greenwich
Technology Investment Capital Corp
- 8 Sound Shore Dr
- Greenwich, Connecticut
- 6830
- Phone: (203) 983-5275
- Website
Description
TICC Capital Corp. (NasdaqGS: TICC) is a business development company primarily engaged in providing debt capital to a wide-range of U.S.-based companies. Our investment activities are managed by TICC Management, LLC, an investment adviser that is registered under the Investment Advisers Act of 1940.
Mr. O'Brien has 28 years of experience in the securities industry. Mr. O'Brien retired as a Managing Director of Merrill Lynch & Co. in 1999 after working in the Equity Capital Markets area since he joined Merrill Lynch & Co. in 1971, during which time he created the Equity Transaction Group in 1985, helped launch Merrill Lynch's London-based Equity Capital Markets Group and had primary responsibility for the pricing of all equity and convertible issues managed by Merrill Lynch. Mr. O’Brien was a member of the Board of Trustees of Colgate University from May 1996 to May 2005.
Mr. Cohen is the Chief Executive Officer of TICC Capital Corp. Mr. Cohen is also the Chief Executive Officer of Oxford Lane Capital Corp. (NasdaqGS: OXLC). Previously, Mr. Cohen managed technology research groups at Wit SoundView, Merrill Lynch & Co., UBS Securities and Salomon Smith Barney. Mr. Cohen has more than 15 years of experience in technology-related equity research and was named to the Institutional Investor "All-American" research team in 1996, 1997 and 1998. Mr. Cohen received a Bachelor of Arts degree in Economics from Connecticut College and an M.B.A. from Columbia University.
Mr. Novak has 30 years of experience in securities investment and finance. Mr. Novak currently serves as Chairman at Mederi Therapeutics, Inc. a manufacturer and marketer of medical devices and as a Board Member at Aperio Technologies, Inc. Previously, Mr. Novak served as President of Palladio Capital Management, LLC and as the Principal and Managing Member of the General Partner of Palladio Partners, LP. Prior to founding Palladio, Mr. Novak was a Managing Director of C.E. Unterberg, Towbin from February 1993 through December 2001. During his tenure at Unterberg, Mr.
TICC Capital Corp. is a closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to maximize our portfolio’s total return. Our primary focus is to seek current income by investing primarily in corporate debt securities.